Related Experiment Video
Updated: Feb 20, 2026

Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting
Published on: March 1, 2019
Protoparvovirus Cell Entry.
Carlos Ros1, Nooshin Bayat2, Raphael Wolfisberg3
1Department of Chemistry and Biochemistry, University of Bern, 3012 Bern, Switzerland. carlos.ros@dcb.unibe.ch.
Protoparvoviruses (PtPVs) are studied for their potential in cancer therapy due to their oncotropism and oncolytic activity. Understanding how these viruses enter cells and deliver their genome is key to enhancing their anticancer applications and safety.
Area of Science:
- Virology
- Molecular Biology
- Oncology
Background:
- The Protoparvovirus (PtPV) genus, part of the Parvoviridae family, comprises significant animal pathogens and serves as a model for the entire family.
- Certain PtPVs show promise as anticancer agents due to their tumor-targeting (oncotropic) and tumor-destroying (oncolytic) properties, while remaining non-pathogenic to humans.
Purpose of the Study:
- To review the molecular mechanisms governing Protoparvovirus (PtPV) entry into host cells.
- To elucidate how PtPVs deliver their single-stranded DNA genome into the host cell nucleus.
- To identify strategies for enhancing the anticancer therapeutic potential and safety profile of PtPVs.
Main Methods:
- Review of existing literature on PtPV molecular interactions.
- Analysis of capsid structural transitions during viral entry.
- Examination of cellular processes hijacked by PtPVs for nuclear delivery.
Main Results:
- PtPVs utilize host cell machinery for nuclear transport, transcription, and replication.
- Viral entry involves overcoming intracellular barriers and trafficking through various cellular compartments, impacting infection efficiency.
- Mechanisms of PtPV nuclear entry involve intricate molecular interactions and capsid dynamics.
Conclusions:
- Understanding PtPV entry mechanisms is crucial for optimizing their use as oncolytic viruses.
- Further research into PtPV-host interactions can lead to improved cancer therapies.
- Enhancing PtPV delivery efficiency and safety is a key goal for therapeutic development.
Related Concept Videos
Retrovirus Life Cycles
Intracellular Movement of Viruses and Bacteria
Receptor-mediated Endocytosis
Clathrin-Mediated Endocytosis of LDL
One well-characterized example of receptor-mediated endocytosis is the...
Introduction to Virus
Retroviruses
Coat Assembly and GTPases
Coat assembly depends on the local availability of phosphatidylinositol phosphates or PIPs and GTP-binding proteins. Adaptor proteins, which link the coat proteins to the membrane, bind to these PIPs and play a crucial role in controlling...

